Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Treating Locally Advanced or Metastatic Angiosarcomas
NCT00874874Phase 2Completed
- Sponsor
- Centre Oscar Lambret
- Start
- May 2008
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in angiosarcoma, sponsored by Centre Oscar Lambret. Started May 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
angiosarcoma
Beyond the preview
Go deeper on NCT00874874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874874.